Efficacy and Safety of Two Glucocorticoid Regimens in the Treatment of Sarcoidosis

PHASE4CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

October 7, 2022

Study Completion Date

October 31, 2022

Conditions
Sarcoidosis
Interventions
DRUG

Low dose prednisolone

An initial dose of 20 mg/day will be administered for 8 weeks, followed by 15 mg/day for 8 weeks, 10 mg/day for 4 weeks, and 5 mg/day for 4 weeks, after which the drug will be tapered over 2 weeks and discontinued.

DRUG

Medium dose prednisolone

An initial dose of 40 mg/day will be administered for 4 weeks, followed by 30 mg/day for 4 weeks, 20 mg/day for 4 weeks, 15 mg/day for 4 weeks, 10 mg/day for 4 weeks, and 5 mg/day for 4 weeks, after which the drug will be tapered over 2 weeks and discontinued.

Trial Locations (1)

160012

Postgraduate Institute of Medical Education and Research, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT03265405 - Efficacy and Safety of Two Glucocorticoid Regimens in the Treatment of Sarcoidosis | Biotech Hunter | Biotech Hunter